Literature DB >> 18484953

Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.

W Barcelos1, R Sathler-Avelar, O A Martins-Filho, B N Carvalho, T M P D Guimarães, S S Miranda, H M Andrade, M H P Oliveira, V P C P Toledo.   

Abstract

Herein, we intended to perform flow-cytometric analyses of peripheral blood NK-cell subsets in patients with active tuberculosis (TB) and those putative resistant subjects displaying positive tuberculin skin test (TST+) and compared with TST- healthy controls. Our findings demonstrated distinct phenotypic features in TST+ as compared with TB. While lower values of NK-cells with increased frequency of CD3-CD16+ CD56- and CD3-CD16-CD56+ subsets besides lower frequency of CD3-CD16+ CD56+ NK-cells was observed in TST+, unaltered levels of NK-cells with increased levels of CD3-CD16+ CD56- NK-cells with lower frequency of CD3-CD16+ CD56+ NK-cells was found in TB. Additional analysis highlighted a shift towards increased levels of CD3-CD16-/+CD56bright NK-cells as the hallmark of TST+, whereas unaltered frequency was observed in TB. Increased levels of CD3+CD56+ cells were observed in both TST+ and TB. Further focusing on the monocyte/NK-cell network, we have reported that enhanced frequency of CD14+ CD16+ monocytes particularly observed in TST+. Outstanding were the distinct correlation profiles observed between CD3-CD16-CD56+ NK-cells and CD3+ CD56+ cells CD14+ CD16+ monocytes for TST+ and TB. These data suggested that high levels of CD3-CD16-CD56+ NK-cells aside CD14+ CD16+ monocytes as well as non-concurrent increment of CD3+ CD56+ cells, may be involved in protective mechanisms in putative tuberculosis-resistant individuals. On the other hand, the basal levels of macrophage-like monocytes despite its positive correlation with increased levels of CD3+ CD56+ cells may count for the lack of the protective immunity in patients with active tuberculosis. Further studies focusing on the cytokine profiling of peripheral blood innate immunity cells before and after chemotherapeutic treatment are currently under evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 18484953     DOI: 10.1111/j.1365-3083.2008.02116.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  15 in total

Review 1.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

2.  Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection.

Authors:  Rassamon Keawvichit; Ladawan Khowawisetsut; Sakaorat Lertjuthaporn; Kanchana Tangnararatchakit; Nopporn Apiwattanakul; Sutee Yoksan; Ampaiwan Chuansumrit; Kulkanya Chokephaibulkit; Aftab A Ansari; Nattawat Onlamoon; Kovit Pattanapanyasat
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

3.  Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype.

Authors:  Damien Portevin; Laura E Via; Seokyong Eum; Douglas Young
Journal:  Cell Microbiol       Date:  2012-07-30       Impact factor: 3.715

4.  Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis.

Authors:  José Alberto Choreño-Parra; Luis Armando Jiménez-Álvarez; Ellis Daniela Maldonado-Díaz; Graciela Cárdenas; Luis Alejandro Fernández-Lopez; José Luis Soto-Hernandez; Marcela Muñoz-Torrico; Gustavo Ramírez-Martínez; Alfredo Cruz-Lagunas; Armando Vega-López; María Lilia Domínguez-López; Carlos Sánchez-Garibay; Parménides Guadarrama-Ortíz; Silvia Giono; Luis Antonio Jiménez-Zamudio; Shabaana A Khader; Ethel A García-Latorre; Citlaltepetl Salinas-Lara; Joaquín Zúñiga
Journal:  J Immunol Res       Date:  2021-04-27       Impact factor: 4.818

5.  Lymphocyte subpopulations in myocardial infarction: a comparison between peripheral and intracoronary blood.

Authors:  Natalia Lluberas; Natalia Trías; Andreína Brugnini; Rafael Mila; Gustavo Vignolo; Pedro Trujillo; Ariel Durán; Sofía Grille; Ricardo Lluberas; Daniela Lens
Journal:  Springerplus       Date:  2015-12-01

6.  Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.

Authors:  Carolina Inés Domaica; Mercedes Beatriz Fuertes; Ignacio Uriarte; María Victoria Girart; Jessica Sardañons; Dorina Ileana Comas; Daniela Di Giovanni; María Isabel Gaillard; Liliana Bezrodnik; Norberto Walter Zwirner
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

7.  Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.

Authors:  Suvercha Bhardwaj; Fareed Ahmad; Heiner Wedemeyer; Marcus Cornberg; Julian Schulze Zur Wiesch; Jan van Lunzen; Shiv K Sarin; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  Virol J       Date:  2016-04-18       Impact factor: 4.099

8.  High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults.

Authors:  Sanjana Mahapatra; Emily M Mace; Charles G Minard; Lisa R Forbes; Alexander Vargas-Hernandez; Teresa K Duryea; George Makedonas; Pinaki P Banerjee; William T Shearer; Jordan S Orange
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

Review 9.  Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?

Authors:  José Alberto Choreño Parra; Nayeli Martínez Zúñiga; Luis Antonio Jiménez Zamudio; Luis Armando Jiménez Álvarez; Citlaltepetl Salinas Lara; Joaquín Zúñiga
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

Review 10.  Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection.

Authors:  Pavithra Sampath; Kadar Moideen; Uma Devi Ranganathan; Ramalingam Bethunaickan
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.